M
Maddalena Trombetta
Researcher at University of Verona
Publications - 62
Citations - 1512
Maddalena Trombetta is an academic researcher from University of Verona. The author has contributed to research in topics: Diabetes mellitus & Type 2 diabetes. The author has an hindex of 19, co-authored 49 publications receiving 1221 citations.
Papers
More filters
Journal ArticleDOI
β-Cell function across the spectrum of glucose tolerance in obese youth
Ram Weiss,Sonia Caprio,Maddalena Trombetta,Sara E. Taksali,William V. Tamborlane,Riccardo C. Bonadonna +5 more
TL;DR: Obese youth with IGT have a significant defect in first-phase insulin secretion, while a defect in second-phase secretion and proinsulin processing is specific for type 2 diabetes in this age-group.
Journal ArticleDOI
Nonalcoholic Fatty Liver Disease Is Independently Associated With an Increased Incidence of Chronic Kidney Disease in Patients With Type 1 Diabetes
Giovanni Targher,Alessandro Mantovani,Isabella Pichiri,Lucia Mingolla,Valentina Cavalieri,William Mantovani,Serena Pancheri,Maddalena Trombetta,Giacomo Zoppini,Michel Chonchol,Christopher D. Byrne,Enzo Bonora +11 more
TL;DR: Measurement of NAFLD improves risk prediction for CKD, independently of traditional cardio-renal risk factors, in patients with type 1 diabetes, in a first study to demonstrate thatNAFLD is strongly associated with an increased incidence of CKD.
Journal ArticleDOI
Elevated 1-Hour Postload Plasma Glucose Levels Identify Subjects With Normal Glucose Tolerance but Impaired β-Cell Function, Insulin Resistance, and Worse Cardiovascular Risk Profile: The GENFIEV Study
Cristina Bianchi,Roberto Miccoli,Maddalena Trombetta,Francesco Giorgino,Simona Frontoni,Emanuela Faloia,Giulio Marchesini,M. A. Dolci,Franco Cavalot,Gisella M. Cavallo,Frida Leonetti,Riccardo C. Bonadonna,Stefano Del Prato +12 more
TL;DR: Among subjects with NGT, those with 1-hour OGTT glucose of >155 mg/dL showed lower insulin sensitivity, impaired β-cell function, and worse cardiovascular risk profile and therefore are at greater risk of developing T2DM and cardiovascular disease.
Type 2 diabetes and chronic liver disease in the Verona diabetes study
TL;DR: The Verona diabetes study as discussed by the authors showed an increased risk of mortality from liver cirrhosis and liver cancer in type 2 diabetic patients after 5 years of follow-up, and this risk increased significantly in obese patients (body mass index > 30 kg/m 2 ).
Journal ArticleDOI
Review article: type 2 diabetes and chronic liver disease in the Verona diabetes study.
TL;DR: The Verona diabetes study showed an increased risk of mortality from liver cirrhosis and liver cancer in type 2 diabetic patients and this risk increased significantly in obese patients (body mass index >30 kg/m2).